Item 1. Financial Statements
ACCRETION ACQUISITION CORP.
CONDENSED BALANCE SHEETS
​
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | September 30, 2022 | ​ | December 31, 2021 |
| ​ | (Unaudited) | ​ |
| Assets | ​ | ​ | ​ | ​ | ​ | ​ |
| Cash | ​ | $ | 255,951 | ​ | $ | 661,776 |
| Prepaid expenses - current | ​ | 299,590 | ​ | 315,012 |
| Total Current Assets | ​ | ​ | 555,541 | ​ | ​ | 976,788 |
| Cash held in Trust Account | ​ | ​ | 210,308,794 | ​ | ​ | 209,072,882 |
| Prepaid expenses - non current | ​ | ​ | 17,238 | ​ | ​ | 241,314 |
| Total Assets | ​ | $ | 210,881,573 | ​ | $ | 210,290,984 |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit | ​ | ​ |
| Current Liabilities | ​ | ​ | ​ | ​ | ​ | ​ |
| Accrued expenses | ​ | $ | 596,924 | ​ | $ | 98,495 |
| Related party payable | ​ | ​ | 112,318 | ​ | ​ | 22,258 |
| Income tax payable | ​ | ​ | 208,777 | ​ | ​ | — |
| Franchise tax payable | ​ | ​ | 79,175 | ​ | ​ | 118,177 |
| Total Current Liabilities | ​ | ​ | 997,194 | ​ | ​ | 238,930 |
| Deferred underwriting commission | ​ | 7,245,000 | ​ | 7,245,000 |
| Total Liabilities | ​ | 8,242,194 | ​ | 7,483,930 |
| ​ | ​ | ​ | ​ | ​ |
| Commitments and Contingencies (Note 6) | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Common stock subject to possible redemption, $ 0.001 par value; 20,700,000 shares at $ 10.16 per share redemption value as of September 30, 2022 and at $ 10.10 per share redemption value as of December 31, 2021 | ​ | 210,308,794 | ​ | 209,070,000 |
| ​ | ​ | ​ |
| Stockholders’ Deficit | ​ | ​ | ​ | ​ | ​ | ​ |
| Preferred stock, $ 0.001 par value; 1,000,000 shares authorized; none issued or outstanding | ​ | ​ | — | ​ | ​ | — |
| Common stock, $ 0.001 par value; 50,000,000 shares authorized; 5,295,000 shares issued and outstanding | ​ | 5,295 | ​ | 5,295 |
| Additional paid-in capital | ​ | — | ​ | — |
| Accumulated deficit | ​ | ( 7,674,710 ) | ​ | ( 6,268,241 ) |
| Total Stockholders’ Deficit | ​ | ( 7,669,415 ) | ​ | ( 6,262,946 ) |
| Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit | ​ | $ | 210,881,573 | ​ | $ | 210,290,984 |

​
The accompanying notes are an integral part of the unaudited condensed financial statements.
​
​
3
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | For the period from |
| ​ | ​ | For the Three | ​ | For the Three | ​ | For the Nine | ​ | February 26, 2021 |
| ​ | ​ | Months Ended | ​ | Months Ended | ​ | Months Ended | ​ | (inception) through |
| ​ | September 30, 2022 | September 30, 2021 | September 30, 2022 | September 30, 2021 |
| Formation and operating costs | ​ | $ | 232,400 | ​ | $ | — | ​ | $ | 1,068,370 | ​ | $ | 1,359 |
| Stock-based compensation | ​ | ​ | — | ​ | ​ | 1,700,000 | ​ | ​ | — | ​ | ​ | 1,700,000 |
| Franchise tax expense | ​ | ​ | 50,000 | ​ | ​ | — | ​ | ​ | 150,000 | ​ | ​ | — |
| Loss on operations | ​ | ​ | ( 282,400 ) | ​ | ​ | ( 1,700,000 ) | ​ | ​ | ( 1,218,370 ) | ​ | ​ | ( 1,701,359 ) |
| Other income: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Dividends earned from Trust Account | ​ | ​ | 945,302 | ​ | ​ | — | ​ | ​ | 1,259,472 | ​ | ​ | — |
| Profit (loss) before provision for income taxes | ​ | ​ | 662,902 | ​ | ​ | ( 1,700,000 ) | ​ | ​ | 41,102 | ​ | ​ | ( 1,701,359 ) |
| Income tax expense | ​ | ​ | ( 188,013 ) | ​ | ​ | — | ​ | ​ | ( 208,777 ) | ​ | ​ | — |
| Net profit (loss) | ​ | $ | 474,889 | ​ | $ | ( 1,700,000 ) | ​ | $ | ( 167,675 ) | ​ | $ | ( 1,701,359 ) |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Basic and diluted weighted average shares outstanding of redeemable common stock | ​ | 20,700,000 | ​ | ​ | — | ​ | ​ | 20,700,000 | ​ | — |
| Basic and diluted net profit (loss) per share, redeemable common stock | ​ | $ | 0.02 | ​ | $ | — | ​ | $ | ( 0.01 ) | ​ | $ | — |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Basic and diluted weighted average shares outstanding of non-redeemable common stock | ​ | 5,295,000 | ​ | ​ | 4,620,000 | ​ | ​ | 5,295,000 | ​ | 4,594,884 |
| Basic and diluted net profit (loss) per share, non-redeemable common stock | ​ | $ | 0.02 | ​ | $ | ( 0.37 ) | ​ | $ | ( 0.01 ) | ​ | $ | ( 0.37 ) |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | Total |
| ​ | ​ | Common Stock | ​ | Paid-in | ​ | Accumulated | ​ | Stockholders’ |
| ​ | Shares | Amount | Capital | Deficit | Deficit |
| Balance – December 31, 2021 (audited) | ​ | 5,295,000 | ​ | $ | 5,295 | ​ | $ | — | ​ | $ | ( 6,268,241 ) | ​ | $ | ( 6,262,946 ) |
| Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ( 540,145 ) | ​ | ​ | ( 540,145 ) |
| Balance - March 31, 2022 (unaudited) | ​ | 5,295,000 | ​ | ​ | 5,295 | ​ | ​ | — | ​ | ​ | ( 6,808,386 ) | ​ | ​ | ( 6,803,091 ) |
| Remeasurement of common stock to redemption amount | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ( 317,051 ) | ​ | ​ | ( 317,051 ) |
| Net loss | — | ​ | — | ​ | — | ​ | ( 102,419 ) | ​ | ( 102,419 ) |
| Balance - June 30, 2022 (unaudited) | 5,295,000 | ​ | ​ | 5,295 | ​ | ​ | — | ​ | ​ | ( 7,227,856 ) | ​ | ​ | ( 7,222,561 ) |
| Remeasurement of common stock to redemption amount | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ( 921,743 ) | ​ | ​ | ( 921,743 ) |
| Net profit | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 474,889 | ​ | ​ | 474,889 |
| Balance - September 30, 2022 (unaudited) | ​ | 5,295,000 | ​ | $ | 5,295 | ​ | $ | — | ​ | $ | ( 7,674,710 ) | ​ | $ | ( 7,669,415 ) |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | Additional | ​ | ​ | ​ | ​ | Total |
| ​ | ​ | Common Stock | ​ | Paid-in | ​ | Accumulated | ​ | Stockholders’ |
| ​ | Shares | Amount | Capital | Deficit | Equity |
| Balance - February 26, 2021 (inception) | ​ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — |
| Issuance of common stock to Sponsor | ​ | 5,175,000 | ​ | ​ | 5,175 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 5,175 |
| Net loss | — | ​ | — | ​ | — | ​ | ( 780 ) | ​ | ( 780 ) |
| Balance - March 31, 2021 (unaudited) | 5,175,000 | ​ | ​ | 5,175 | ​ | ​ | — | ​ | ​ | ( 780 ) | ​ | ​ | 4,395 |
| Issuance of common stock to Sponsor | ​ | — | ​ | ​ | — | ​ | ​ | 19,825 | ​ | ​ | — | ​ | ​ | 19,825 |
| Issuance of EBC Founder Shares | ​ | 120,000 | ​ | ​ | 120 | ​ | ​ | 460 | ​ | ​ | — | ​ | ​ | 580 |
| Net loss | ​ | — | ​ | — | ​ | — | ​ | ( 579 ) | ​ | ( 579 ) |
| Balance - June 30, 2021 (unaudited) | ​ | 5,295,000 | ​ | ​ | 5,295 | ​ | ​ | 20,285 | ​ | ​ | ( 1,359 ) | ​ | ​ | 24,221 |
| Transfer of Founder Shares to Independent Directors | ​ | — | ​ | ​ | — | ​ | ​ | 1,700,000 | ​ | ​ | — | ​ | ​ | 1,700,000 |
| Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | ( 1,700,000 ) | ​ | ​ | ( 1,700,000 ) |
| Balance - September 30, 2021 (unaudited) | ​ | 5,295,000 | ​ | $ | 5,295 | ​ | $ | 1,720,285 | ​ | $ | ( 1,701,359 ) | ​ | $ | 24,221 |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | ​ | ​ | For the period from |
| ​ | ​ | For the Nine | ​ | February 26, 2021 |
| ​ | ​ | Months Ended | ​ | (inception) through |
| ​ | September 30, 2022 | September 30, 2021 |
| Cash Flows from Operating Activities: | ​ | ​ | ​ | ​ | ​ |
| Net loss | ​ | $ | ( 167,675 ) | ​ | $ | ( 1,701,359 ) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ​ | ​ | ​ | ​ | ​ |
| Dividends earned from Trust Account | ​ | ​ | ( 1,259,472 ) | ​ | ​ | — |
| Stock-based compensation | ​ | ​ | — | ​ | ​ | 1,700,000 |
| Changes in operating assets and liabilities: | ​ | ​ |
| Prepaid expenses - current | ​ | ​ | 15,423 | ​ | ​ | — |
| Prepaid expenses - non-current | ​ | 224,076 | ​ | — |
| Accrued expenses | ​ | ​ | 498,429 | ​ | ​ | 1,359 |
| Related party payable | ​ | ​ | 90,060 | ​ | ​ | — |
| Income tax payable | ​ | ​ | 208,777 | ​ | ​ | — |
| Franchise tax payable | ​ | ​ | ( 39,002 ) | ​ | ​ | — |
| Net cash used in operating activities | ​ | ( 429,384 ) | ​ | — |
| Cash Flows from Investing Activities: | ​ | ​ | ​ | ​ | ​ | ​ |
| Transfer from Trust Account | ​ | ​ | 23,559 | ​ | ​ | — |
| Net cash provided by investing activities | ​ | ​ | 23,559 | ​ | ​ | — |
| Cash Flows from Financing Activities: | ​ | ​ |
| Proceeds from issuance of common stock to Sponsor | ​ | — | ​ | 25,000 |
| Proceeds from promissory note - related party | ​ | — | ​ | 150,000 |
| Payment of offering costs | ​ | ​ | — | ​ | ​ | ( 103,711 ) |
| Net cash provided by financing activities | ​ | — | ​ | 71,289 |
| ​ | ​ | ​ |
| Net change in cash: | ​ | ( 405,825 ) | ​ | 71,289 |
| Cash - Beginning | ​ | 661,776 | ​ | — |
| Cash - Ending | ​ | $ | 255,951 | ​ | $ | 71,289 |
| ​ | ​ | ​ | ​ | ​ |
| Supplemental disclosure of non-cash financing activities: | ​ | ​ | ​ | ​ |
| Deferred offering costs included in accrued expenses | ​ | $ | — | ​ | $ | 276,672 |
| Deferred offering costs paid through promissory note - related party | ​ | $ | — | ​ | $ | 91,211 |
| Issuance of EBC Founder Shares | ​ | $ | — | ​ | $ | 580 |
| Remeasurement of common stock subject to redemption to redemption value | ​ | $ | 1,238,794 | ​ | $ | — |

ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 1 ─ ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONSAccretion Acquisition Corp. (the “Company”) was incorporated in Delaware on February 26, 2021. The Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, however, the Company intends to concentrate its efforts to focus identifying businesses in the upstream energy industry or in related businesses in the midstream, services, software or commodity risk management sectors. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.As of September 30, 2022, the Company had not commenced any operations. All activity for the period from February 26, 2021 (inception) through September 30, 2022, relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income or dividend income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.On October 25, 2021, the Company closed its Initial Public Offering of 18,000,000 units at $ 10.00 per unit (the “Units” and, with respect to the shares of common stock included in the Units, the “Public Shares”) which is discussed in Note 3 and the sale of 7,300,000 warrants (each, a “Private Warrant” and collectively, the “Private Warrants”) at a price of $ 1.00 per Private Warrant in a private placement to its sponsor, Accretion Acquisition Sponsor, LLC (the “Sponsor”) and its underwriters that closed simultaneously with the closing of the Initial Public Offering (as described in Note 4). The Company has listed the Units on the Nasdaq Capital Market (“Nasdaq”).Transaction costs amounted to $ 11.94 million consisting of $ 4.14 million in cash of underwriting commissions, $ 7.25 million of deferred underwriting commissions and $ 0.55 million of other offering costs.The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80 % of the net assets held in the Trust Account (as defined below, net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions) at the time of the Company’s signing a definitive agreement in connection with its initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50 % or more of the outstanding voting securities of the target or otherwise acquires an interest in the target business or assets sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).Upon the closing of the Initial Public Offering on October 25, 2021, the Company deposited $ 181.80 million ($ 10.10 per Unit) from the proceeds of the Initial Public Offering in the trust account (“Trust Account”), located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.​ 7
ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 1 ─ ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)On October 27, 2021, the underwriters exercised their over-allotment option in full (see Note 6), according to which, on October 28, 2021, the Company consummated the sale of an additional 2,700,000 Units, at $ 10.00 per Unit, and the sale of an additional 810,000 Private Warrants, at $ 1.00 per Private Warrant, generating total gross proceeds of $ 27.81 million, and incurring additional cash underwriting commissions of approximately $ 0.54 million and deferred underwriting discount of approximately $ 0.95 million. The proceeds from the sale of the additional Units were deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to $ 209.07 million.The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $ 10.10 per Public Share, plus any pro rata income earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.”The Company will only proceed with a Business Combination if the Company has net tangible assets of at least $ 5,000,001 either prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange rules and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by applicable law or stock exchange rules, or the Company decides to obtain stockholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.Notwithstanding the above, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Public Shares, without the prior consent of the Company.The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares (as defined in Note 5) and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100 % of its Public Shares if the Company does not complete a Business Combination or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.​ 8
ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 1 ─ ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)The Company will have until 18 months from the closing of the Initial Public Offering to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including income earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations (less up to $ 100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares (as defined in Note 5) if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit of $ 10.10 .In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $ 10.10 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.Liquidity and Going ConcernAs of September 30, 2022, the Company had $ 0.26 million in its operating bank account, and $ 210.31 million of cash held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and a working capital deficiency of $ 0.44 million.Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. 9
ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 1 ─ ORGANIZATION AND DESCRIPTION OF BUSINESS OPERATIONS (Continued)Liquidity and Going Concern (Continued)The Company will need to raise additional capital through loans or additional investments through April 25, 2023 from its Sponsor, stockholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.Risks and UncertaintiesManagement continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these evets, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.​ ​ NOTE 2 ─ SIGNIFICANT ACCOUNTING POLICIES Basis of PresentationThe accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The Company has reclassified certain prior-year amounts to conform to the current-year’s presentation. See Note 5 for further information.The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, 2021, as filed with the SEC on March 31, 2022. The interim results for the three months ended September 30, 2022 are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future periods. 10
ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 2 ─ SIGNIFICANT ACCOUNTING POLICIES (Continued) Emerging Growth CompanyThe Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as amended by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of EstimatesThe preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates. Cash and Cash EquivalentsThe Company had $ 0.26 million in cash as of September 30, 2022 and $ 0.66 million at December 31, 2021. The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did no t have any cash equivalents as of September 30, 2022. Cash Held in Trust AccountOn September 30, 2022, the Company had $ 210.31 million cash held in the Trust Account, and $ 209.07 million at December 31, 2021, that were held in U.S. government treasury obligations with maturities of 185 days or less, which were invested in U.S. Treasury Securities. ​ 11
| ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | As of | ​ | As of |
| ​ | ​ | September 30, 2022 | December 31, 2021 |
| Gross proceeds | ​ | $ | 207,000,000 | ​ | $ | 207,000,000 |
| Less: | ​ | ​ |
| Proceeds allocated to public warrants | ​ | ( 3,321,653 ) | ​ | ( 3,321,653 ) |
| Proceeds allocated to rights issue | ​ | ( 16,892,298 ) | ​ | ( 16,892,298 ) |
| Issuance cost of redeemable common stock | ​ | ( 10,763,962 ) | ​ | ( 10,763,962 ) |
| Plus: | ​ | ​ |
| Remeasurement of carrying value to redemption value | ​ | 34,286,707 | ​ | 33,047,913 |
| Contingently redeemable common stock | ​ | $ | 210,308,794 | ​ | $ | 209,070,000 |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | For the Three | For the Six | For the period from |
| ​ | ​ | For the Three | ​ | Months Ended | ​ | Months Ended | ​ | February 26, 2021 |
| ​ | ​ | Months Ended | ​ | September 30, | ​ | September 30, | ​ | (inception) through |
| ​ | ​ | September 30, 2022 | ​ | 2021 | ​ | 2022 | ​ | September 30, 2021 |
| Redeemable common stock | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Numerator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Net profit (loss) allocable to common stock subject to possible redemption | ​ | $ | 378,157 | ​ | $ | — | ​ | $ | ( 133,521 ) | ​ | $ | — |
| Denominator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Weighted average shares outstanding, redeemable common stock | ​ | 20,700,000 | ​ | — | ​ | 20,700,000 | ​ | — |
| Basic and diluted net profit (loss) per share, redeemable common stock | ​ | $ | 0.02 | ​ | $ | — | ​ | $ | ( 0.01 ) | ​ | $ | — |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Non-redeemable common stock | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Numerator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Net profit (loss) allocable to non-redeemable common stock | ​ | $ | 96,732 | ​ | $ | ( 1,700,000 ) | ​ | $ | ( 34,154 ) | ​ | $ | ( 1,701,359 ) |
| Denominator: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| Weighted average shares outstanding, non-redeemable common stock | ​ | 5,295,000 | ​ | 4,620,000 | ​ | 5,295,000 | ​ | 4,594,884 |
| Basic and diluted net profit (loss) per share, non-redeemable common stock | ​ | $ | 0.02 | ​ | $ | ( 0.37 ) | ​ | $ | ( 0.01 ) | ​ | $ | ( 0.37 ) |

ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 2 ─ SIGNIFICANT ACCOUNTING POLICIES (Continued) Income TaxesThe Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.The Company recorded income tax expense of $ 0.21 million based on activities through September 30, 2022, primarily as a result of significant expenses not currently deductible for U.S. income tax purposes.The Company’s effective tax rate (“ETR”) from continuing operations was 28.4 % and 508.0 % for the three months and nine months ended September 30, 2022, respectively. The variation in the Company’s ETR’s is largely due to the full valuation allowance provided for against start-up costs, which are not currently deductible for tax purposes, as well as how those start-up costs were incurred throughout the year relative to dividend income that was earned from Trust Account.On August 16, 2022, the Inflation Reduction Act (the “IRA”) was signed into law in the U.S. Among other changes, the IRA introduced a corporate minimum tax on certain corporations with average adjusted financial statement income over a three-tax year period in excess of $ 1.0 billion, an excise tax on certain stock repurchases by certain covered corporations for taxable years beginning after December 31, 2022, and several tax incentives to promote clean energy. Based on our current analysis and pending future guidance to be issued by Treasury, we believe the excise tax could apply to the Company after the effective date whether or not a Business Combination is completed; however, we do not believe any other provisions of the IRA will apply to the Company absent a Business Combination.The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.The Company records uncertain tax positions in accordance with ASC 740 on the basis of a two-step process whereby (1) it determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority.The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the accompanying condensed statements of operations. WarrantsASC 480 requires a reporting entity to classify certain freestanding financial instruments as liabilities (or in some cases as assets). ASC 480-10-S99 addresses concerns raised by the SEC regarding the financial statements classification and measurement of securities subject to mandatory redemption requirements or whose redemption is outside the control of the issuer. If the stock subject to mandatory redemption provisions represents the only shares in the reporting entity, it must report instruments in the liabilities section of its statement of financial position. The stock subject must then describe them as shares subject to mandatory redemption, so as to distinguish the instruments from other financial statements liabilities. The Company concludes that the Public Warrants (defined in Note 3) do not exhibit any of the above characteristics and, therefore, are outside the scope of ASC 480.In addition to the 16,300,000 warrants (representing 9,000,000 Public Warrants (as defined at Note 3) included in the units and 7,300,000 Private Warrants) issued by the Company at the close of the Initial Public Offering, a further 2,160,000 warrants (representing 1,350,000 Public Warrants (as defined at Note 3) included in the units and 810,000 Private Warrants) were issued as a result of the underwriters’ full exercise of the over-allotment option. All warrants were issued in accordance with the guidance contained in ASC 14
ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity. Such guidance provides that because the warrants meet the criteria for equity treatment. 15
ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 2 ─ SIGNIFICANT ACCOUNTING POLICIES (Continued) Recent Accounting PronouncementsIn August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments.ASU 2020-06 is effective December 15, 2021 and should be applied on a full or modified retrospective basis. On February 26, 2021, the date of the Company’s inception, the Company adopted the new standard.Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. ​ NOTE 3 ─ INITIAL PUBLIC OFFERINGPursuant to the Initial Public Offering, the Company sold 18,000,000 Units at a purchase price of $ 10.00 per Unit. Each Unit consists of one share of common stock, one right (“Right”) and one-half of one warrant (“Public Warrant”). Each Right will convert to one-tenth (1/10) share of common stock upon consummation of Business Combination (see Note 7). Each whole Public Warrant will entitle the holder to purchase one share of common stock at an exercise price of $ 11.50 per share, subject to adjustment (see Note 7).On October 27, 2021, the underwriters fully exercised their over-allotment option and, on October 28, 2021, purchased an additional 2,700,000 Units, generating additional gross proceeds of approximately $ 27.00 million, and incurring additional cash underwriting commissions of approximately $ 0.54 million and deferred underwriting discount of approximately $ 0.95 million. In connection with the sale of Units pursuant to the over-allotment option, the Company sold an additional 810,000 Private Warrants to the Sponsor and the underwriters generating additional gross proceeds of approximately $ 0.81 million. A total of approximately $ 27.27 million of the net proceeds was deposited into the Trust Account, bringing the aggregate proceeds held in the Trust Account to approximately $ 209.07 million.In connection with the Initial Public Offering, the Company granted the underwriters an option to purchase 2,700,000 shares of the Company’s common stock at the Initial Public Offering price, or $ 10.00 per share, for 45 days commencing on October 25, 2021 (grant date). Since this option extended beyond the closing of the Initial Public Offering, this option feature represented a call option that was accounted for under ASC 480, Distinguishing Liabilities from Equity. Accordingly, the call option has been separately accounted for at a fair value with the change in fair value between the grant date and October 27, 2021 recorded as other income. The Company used the Black-Scholes valuation model to determine the fair value of the call option at the grant date and again at October 27, 2021 (refer to Note 8 for fair value information). ​ NOTE 4 ─ PRIVATE WARRANTS Concurrently with the closing of the Initial Public Offering, the Sponsor and the underwriters purchased an aggregate of 7,300,000 Private Warrants, generating gross proceeds of $ 7.30 million in aggregate in a private placement. Each Private Warrant is exercisable for one share of common stock at a price of $ 11.50 per share, subject to adjustment (see Note 7).As a result of the underwriters’ election to fully exercise their over-allotment option on October 27, 2021, the Sponsor and the underwriters and its designees purchased an additional 810,000 Private Warrants, at a purchase price of $ 1.00 per Private Warrant.If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Warrants will expire worthless. 16
ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) ​ NOTE 5 ─ RELATED PARTY TRANSACTIONSFounder SharesOn April 7, 2021, the Sponsor purchased 4,312,500 shares of the Company’s common stock (the “Founder Shares”) for an aggregate purchase price of $ 25,000 .In September 2021, the Sponsor subsequently transferred an aggregate of 250,000 Founder Shares to the Company’s independent director nominees at the same price originally paid for such shares.The sale of the Founder Shares to the Company’s independent director nominees is in the scope of FASB ASC Topic 718, “Compensation-Stock Compensation” (“ASC 718”). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the grant date. The Company has assessed the fair value associated with the Founder Shares granted. The fair value of the 250,000 Founder Shares granted to the Company’s independent director nominees was $ 1.70 million or $ 6.80 per share. The Founder Shares granted to the Company’s independent director nominees will be offered back to the Sponsor at the same purchase price, in the event a person(s) no longer remained in such designated position upon the consummation of a Business Combination. The Sponsor will have 30 days from the offer date to acquire back these Founder Shares at the same purchase price.In October 2021, the Company effected a dividend of 862,500 of the Company’s Founder Shares, which resulted in an aggregate of 5,175,000 Founder Shares outstanding. All share and associated amounts have been retroactively restated to reflect the share dividend.The Founder Shares include an aggregate of up to 675,000 shares of common stock subject to forfeiture by the Sponsors to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will collectively represent 20 % of the Company’s issued and outstanding shares upon the completion of the Initial Public Offering. On October 27, 2021, the underwriters fully exercised the over-allotment option. Thus, no share of common stock remains subject to forfeiture.Founder Shares are subject to lock-up until the earlier of (A) 180 days after the completion of its initial Business Combination or (B) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after its initial Business Combination that results in all of its public stockholders having the right to exchange their shares of common stock for cash, securities or other property.Promissory Note — Related PartyOn April 7, 2021, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $ 0.15 million. The Promissory Note is non-interest bearing and payable on the earlier of December 31, 2021, or the consummation of the Initial Public Offering. The Promissory Note was repaid in full on October 25, 2021.Related Party LoansIn addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $ 1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity. The warrants would be identical to the Private Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2022 and December 31, 2021, respectively, no Working Capital Loans were outstanding.​ 17
ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 5 ─ RELATED PARTY TRANSACTIONS (Continued)Related Party PayableAs of September 30, 2022, an amount of $ 0.11 million was payable to the Sponsor, in connection with a filing fee of $ 60 paid on behalf of the Company and unpaid administrative support fees of $ 0.11 million.As of December 31, 2021, an amount of $ 0.02 million was payable to the Sponsor, in connection with unpaid administrative support fees. This amount has been reclassified from accrued expenses to related party payable in order to conform to the presentation of this period.Administrative Support AgreementCommencing on the effective date of the Initial Public Offering, the Company agreed to pay the Sponsor a total of up to $ 10,000 per month in the aggregate for up to 18 months for office space, utilities and secretarial and administrative support. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For the three months ended September 30, 2022, the Company accrued $ 0.03 million for these services, and for the nine months ended September 30, 2022, the Company has accrued $ 0.09 million. These amounts are included in the operating costs on accompanying condensed statements of operations. No such amounts were recorded during the three months and nine months ended September 30, 2021. NOTE 6 ─ COMMITMENTS AND CONTINGENCIESRegistration RightsThe holders of the Founder Shares, EBC Founder Shares (as defined in Note 7), and any warrants that may be issued in payment of Working Capital Loans made to Company (and underlying securities) are entitled to registration rights pursuant to an agreement entered into on October 20, 2021. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the EBC Founder Shares (as defined in Note 7) and units issued to the Sponsor, officers, directors or their affiliates in payment of Working Capital Loans made to the Company (or underlying securities) can elect to exercise these registration rights at any time after the consummation of a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering its securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.Underwriting AgreementThe Company had granted the underwriters a 45 -day option from the date of Initial Public Offering to purchase up to 2,700,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions.The underwriters were entitled to an underwriting discount of $ 0.20 per unit, or $ 3.60 million in the aggregate payable upon the closing of the Initial Public Offering. $ 0.35 per unit, or $ 6.30 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.On October 27, 2021, the underwriters fully exercised the over-allotment option. As a result, they were entitled to an additional underwriting discount of $ 0.54 million in cash, and a further deferred underwriting discount of $ 0.95 million.​ 18
ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 6 ─ COMMITMENTS AND CONTINGENCIES (Continued)Advisory AgreementThrough September 30, 2022, the Company entered into an agreement with the M&A advisors (who also served as the Company’s underwriters during the Initial Public Offering) in connection with the evaluation, pursuit and conduct of one or more proposed transactions for a potential Business Combination (the “Advisory Agreement”). At balance sheet date, fees for the services performed were contingent upon the closing of a Business Combination and therefore not included as liabilities on the accompanying condensed balance sheets.Engagement for Legal ServicesThe Company has a contingent fee arrangement with their legal counsel pursuant to which a flat fee of $ 3.00 million is payable to the Company’s legal counsel in the event that the Company completes a Business Combination. In the event the Company does not complete a Business Combination, the Company’s legal counsel will bill the Company the lesser of the actual time incurred or $ 0.10 million.As of September 30, 2022, the Company has accrued an amount of $ 0.47 million. ​ NOTE 7 ─ STOCKHOLDERS’ DEFICITCommon StockThe Company is authorized to issue 50,000,000 shares of common stock with a par value of $ 0.001 per share.At September 30, 2021, there were 5,295,000 shares of common stock issued and outstanding, which such amount having been restated to reflect the share dividend in October 2021 (excluding 18,000,000 shares of common stock subject to possible redemption).Of the 5,295,000 shares of common stock outstanding, an aggregate of up to 675,000 shares were subject to forfeiture, to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the Sponsor will collectively own 20 % of the Company’s issued and outstanding common stock after the Initial Public Offering (assuming Sponsor does not purchase any Public Shares in the Initial Public Offering).As of October 27, 2021, as a result of the underwriters’ full exercise of the over-allotment option, no share of common stock was available for forfeiture.Preferred StockThe Company is authorized to issue 1,000,000 shares of preferred stock, par value $ 0.001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2022 and December 31, 2021, no share of preferred stock was issued or outstanding.RightsEach holder of a Right will receive one-tenth (1/10) share of common stock upon consummation of a Business Combination, even if the holder of such Right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon exchange of the rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a Business Combination as the consideration related thereto has been included in the Unit purchase price paid for by investors in the Initial Public Offering. If the Company enters into a deﬁnitive agreement for a Business Combination in which the Company will not be the surviving entity, the deﬁnitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the common stock will receive in the transaction on an as-converted into common stock basis and each holder of a right will be required to affirmatively covert its rights in order to receive one-tenth (1/10) share underlying each right (without paying additional consideration). The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company).​ 19
| ● | in whole and not in part; |
| ● | at a price of $ 0.01 per warrant; |
| ● | at any time after the warrants become exercisable; |
| ● | upon not less than 30 days ’ prior written notice of redemption to each warrant holder; |
| ● | if, and only if, the reported last sale price of the shares of common stock equals or exceeds $ 18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 -trading day period commencing at any time after the warrants become exercisable and ending on the third business day prior to the notice of redemption to warrant holders; and |
| ● | if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants. |

ACCRETION ACQUISITION CORP.NOTES TO CONDENSED FINANCIAL STATEMENTS(UNAUDITED) NOTE 7 ─ STOCKHOLDERS’ DEFICIT (Continued)Warrants (Continued)In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $ 9.20 per common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60 % of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $ 9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115 % of the greater of (i) Market Value or (ii) the price at which the Company issue the additional shares of common stock or equity-linked securities.The Private Warrants will be identical to the Public Warrants underlying the Units being sold in the Initial Public Offering.EBC Founder SharesIn April 2021, the Company issued to EarlyBirdCapital and its designees 100,000 shares of common stock (the “EBC Founder Shares”) at $ 0.001 per share. The Company accounted for the EBC Founder Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders’ equity. The Company estimated the fair value of EBC Founder Shares to be $ 580 based upon the price of the Founder Shares issued to the Sponsor. In October 2021, the Company effected a dividend of 20,000 of the Company’s EBC Founder Shares, which resulted in an aggregate of 120,000 EBC Founder Shares outstanding. All share and associated amounts have been retroactively restated to reflect the share dividend. The holders of the EBC Founder Shares have agreed not to transfer, assign, or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their redemption rights with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period.The EBC Founder Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(g)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities will not be sold during the Initial Public Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the Initial Public Offering, except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners, provided that all securities so transferred remain subject to the lockup restriction above for the remainder of the time period. ​21
| ● | Level 1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
| ● | Level 2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
| ● | Level 3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing the asset or liability. |
| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | Significant | Significant |
| ​ | Quoted Prices | Other | Other |
| ​ | in Active | Observable | Unobservable |
| ​ | Markets | Inputs | Inputs |
| Description | ​ | (Level 1) | (Level 2) | (Level 3) |
| Assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| U.S Treasury securities | ​ | $ | 210,308,794 | ​ | $ | — | ​ | $ | — |
| ​ | ​ | $ | 210,308,794 | ​ | $ | — | ​ | $ | — |

| ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| ​ | ​ | ​ | Significant | Significant |
| ​ | Quoted Prices | Other | Other |
| ​ | in Active | Observable | Unobservable |
| ​ | Markets | Inputs | Inputs |
| Description | ​ | (Level 1) | (Level 2) | (Level 3) |
| Assets: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ |
| U.S Treasury securities | ​ | $ | 209,072,882 | ​ | $ | — | ​ | $ | — |
| ​ | ​ | $ | 209,072,882 | ​ | $ | — | ​ | $ | — |
| ​ | ​ | ​ | ​ |
| Over allotment option at October 25, 2021 | $ | 597,091 |
| Change in fair value of over allotment option transfer to statement of operations | ​ | ( 81,168 ) |
| Transfer to additional paid-in capital upon exercise of over allotment option | ​ | ( 515,923 ) |
| Over allotment option at December 31, 2021 | ​ | $ | — |

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Accretion Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Accretion Acquisition Sponsor, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its initial public offering filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company formed under the laws of the State of Delaware on February 26, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. We intend to effectuate our business combination using cash from the proceeds of the IPO and the sale of the private warrants, our capital stock, debt or a combination of cash, stock and debt.
All activity through September 30, 2022 relates to our formation, the IPO, and search for a prospective business combination target.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception through September 30, 2022, were organizational activities and those necessary to prepare for the IPO, described below. We do not expect to generate any operating revenues until after the completion of our business combination. We expect to generate non-operating income in the form of interest income or dividend income on cash held in the trust account after the IPO. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2022, we had a net profit of $0.48 million, which consisted of dividend income of $0.95 million, offset by franchise tax expense of $0.05 million, income tax expense of $0.19 million and operating costs of $0.23 million.
For the three months ended September 30, 2021, we had a net loss of $1.70 million, which consisted of stock-based compensation.
For the nine months ended September 30, 2022, we had a net loss of $0.17 million, which consisted of dividend income of $1.26 million, offset by franchise tax expense of $0.15 million, income tax expense of $0.21 million and operating costs of $1.07 million.
24
For the period from February 26, 2021 (inception) through September 30, 2021, we had a net loss of $1.70 million which consisted of formation costs and stock-based compensation.Liquidity and Capital ResourcesAs of September 30, 2022, we had $0.26 million in cash and no cash equivalents.Until the consummation of the IPO, our only source of liquidity was an initial purchase of common stock by the Sponsor and loans from the Sponsor.On October 25, 2021, the Company consummated the IPO of 18,000,000 units, at a price of $10.00 per unit, generating gross proceeds of $180.00 million. Simultaneously with the closing of the IPO, we consummated the sale of 7,300,000 private warrants at a price of $1.00 per warrant in a private placement to Sponsor, generating gross proceeds of $7.30 million. On October 27, 2021, the underwriters exercised the over-allotment option in full and on October 28, 2021, purchased an additional 2,700,000 units, generating gross proceeds of approximately $27.00 million. In connection with the underwriters’ full exercise of the over-allotment option, the Company issued an additional 810,000 private warrants at a price of $1.00 per warrant in a private placement to Sponsor generating gross proceeds of $0.81 million.Following the IPO and the private placement, a total of $209.07 million was placed in the trust account (at $10.10 per Unit). We incurred $11.94 million in transaction costs, including $4.14 million of underwriting fees, $7.25 million of deferred underwriting fees and $0.55 million of other offering costs.As of September 30, 2022, we had cash held in the trust account of $210.31 million. We intend to use substantially all of the funds held in the trust account, including any amounts representing income earned on the trust account, to complete our business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.As of September 30, 2022, we had cash of $0.26 million outside of the trust account. We intend to use the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business combination.In order to fund working capital deficiencies or finance transaction costs in connection with a business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we may repay such loaned amounts out of the proceeds of the trust account released to us. In the event that a business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment. Up to $1.50 million of such loans may be convertible into warrants at the option of the lender. The warrants would be identical to the private warrants.We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our business combination. Moreover, we may need to obtain additional financing either to complete our business combination or because we become obligated to redeem a significant number of our public shares upon consummation of our business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our business combination. If we are unable to complete our business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition, following our business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.25
Going ConcernIn connection with our assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation and subsequent dissolution, should the we be unable to complete a business combination, raises substantial doubt about the our ability to continue as a going concern.Off-Balance Sheet ArrangementsWe have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2022. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.Contractual ObligationsWe do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than as described below.Registration RightsThe holders of the founders’ shares, EBC founder shares, the private warrants, and any warrants that may be issued upon conversion of working capital loans will be entitled to registration rights pursuant to a registration rights agreement. These holders will be entitled to certain demand and “piggyback” registration rights. We will bear the expenses incurred in connection with the filing of any such registration statements.Underwriting AgreementThe underwriters were entitled to an underwriting discount of $0.20 per unit, or $3.60 million in the aggregate payable upon the closing of the IPO and the over-allotment option. $0.35 per unit, or $6.30 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the trust account solely in the event that the Company completes a business combination, subject to the terms of the underwriting agreement.On October 27, 2021, the underwriters fully exercised the over-allotment option. As a result, they were entitled to an additional underwriting discount of $0.54 million in cash, and a further deferred underwriting discount of $0.95 million.Administrative Support AgreementCommencing on the effective date of the IPO, we have agreed to pay the Sponsor a total of up to $10,000 per month in the aggregate for up to 18 months for office space, utilities and secretarial and administrative support. Upon completion of the initial business combination or the Company’s liquidation, we will cease paying these monthly fees. For the three months ended September 30, 2022, the Company accrued $0.03 million for these services, and for the nine months ended September 30, 2022, the Company accrued $0.09 million. These amounts are included in the operating costs on accompanying condensed statements of operations.Advisory AgreementThrough September 30, 2022, the Company entered into an agreement with the M&A advisors (who also served as the Company’s underwriters during the Initial Public Offering) in connection with the evaluation, pursuit and conduct of one or more proposed transactions for a potential Business Combination (the “Advisory Agreement”). At balance sheet date, fees for the services performed were contingent upon the closing of a Business Combination and therefore not included as liabilities on the accompanying condensed balance sheets.26
Engagement for Legal ServicesThe Company has a contingent fee arrangement with their legal counsel pursuant to which a flat fee of $3.00 million is payable to the Company’s legal counsel in the event that the Company completes a Business Combination. In the event the Company does not complete a Business Combination, the Company’s legal counsel will bill the Company the lesser of the actual time incurred or $100,000.As of September 30, 2022, the Company has accrued an amount of $0.47 million.Critical Accounting PoliciesManagement does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. The Company has identified the following as its critical accounting policies:WarrantsWe do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15.We account for the public warrants and private warrants collectively (“Warrants”), as either equity or liability-classified instruments based on an assessment of the specific terms of the Warrants and the applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the Warrants meet all of the requirements for equity classification under ASC 815, including whether the Warrants are indexed to our own common stocks and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of our control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of issuance of the Warrants and as of each subsequent quarterly period end date while the Warrants are outstanding.For issued or modified warrants that meet all of the criteria for equity classification, such warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, such warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of liability-classified warrants are recognized as a non-cash gain or loss on the statements of operations.We evaluated the public warrants and private warrants in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity,” and concluded that they met the criteria for equity classification and are required to be recorded as part a component of additional paid-in capital at the time of issuance.Common Stock Subject to Possible RedemptionWe account for the common stock subject to possible redemption in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity. Common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events.27
Net Profit (Loss) Per Share of Common StockWe comply with accounting and disclosure requirements of Financial Accounting Standards Board Accounting Standard Codification, or FASB ASC, Topic 260, “Earnings Per Share.” Net Profit (loss) per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. The Company applies the two-class method in calculating earnings per share. The calculation of diluted profit (loss) per share of common stock does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.Recent Accounting PronouncementsIn August 2020, FASB issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective December 15, 2021 and should be applied on a full or modified retrospective basis. On February 26, 2021, the date of the Company’s inception, the Company adopted the new standard.Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s condensed financial statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Not required for smaller reporting companies.
Item 4. Controls and Procedures
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2022. Based upon their evaluation, and due to a material weakness in our internal control over financial reporting over the accounting for complex financial instruments, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective as of September 30, 2022.
28
Changes in Internal Control Over Financial ReportingDuring our most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.PART II. OTHER INFORMATION
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 31, 2022. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
We had no sales of unregistered equity securities during the period covered by this Quarterly Report on Form 10-Q.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
Item 6. Exhibits
​
| Exhibit Number | Description of Document |
| 31.1 | ​ | Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2 | ​ | Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1* | ​ | Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 32.2* | ​ | Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 101.SCH | ​ | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | ​ | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | ​ | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | ​ | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | ​ | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | ​ | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set. |

| * | Furnished herewith. |

​
29
| ​ | ​ | ​ |
| ​ | ACCRETION ACQUISITION CORP. |
| ​ | (Registrant) |
| ​ | ​ | ​ |
| Date: November 14, 2022 | By: | /s/ M. Grant Farn |
| ​ | ​ | M. Grant Farn |
| ​ | ​ | Chief Financial Officer |
| ​ | ​ | (Principal Financial Officer) |


Question: How many years could the company sustain the dividend payments at the current rate if the dividends were to be paid solely from the company's Cash on Hand?

Python solution:
def solution():
     #Define variables name and value
    cash_on_hand_sept_2022 = 255951 
    dividends_earned_sept_2022 = 945302  

    #Do math calculation to get the answer
    years_sustainable = cash_on_hand_sept_2022 / dividends_earned_sept_2022
    answer = years_sustainable
    return answer


Answer: 0.2707610901